These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23000300)

  • 1. Confounders of excessive brain volume loss in schizophrenia.
    Van Haren NE; Cahn W; Hulshoff Pol HE; Kahn RS
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2418-23. PubMed ID: 23000300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of brain abnormalities in schizophrenia: can we slow the progression?
    van Haren NE; Cahn W; Hulshoff Pol HE; Kahn RS
    J Psychopharmacol; 2012 May; 26(5 Suppl):8-14. PubMed ID: 21730018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
    Boonstra G; van Haren NE; Schnack HG; Cahn W; Burger H; Boersma M; de Kroon B; Grobbee DE; Hulshoff Pol HE; Kahn RS
    J Clin Psychopharmacol; 2011 Apr; 31(2):146-53. PubMed ID: 21346618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
    Tomelleri L; Jogia J; Perlini C; Bellani M; Ferro A; Rambaldelli G; Tansella M; Frangou S; Brambilla P;
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):835-40. PubMed ID: 19717283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Cahn W; Schnack HG; Janssen J; Klumpers F; Hulshoff Pol HE; Kahn RS
    J Clin Psychiatry; 2010 Jun; 71(6):737-44. PubMed ID: 20492835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphology of the anterior cingulate gyrus in patients with schizophrenia: relationship to typical neuroleptic exposure.
    Kopelman A; Andreasen NC; Nopoulos P
    Am J Psychiatry; 2005 Oct; 162(10):1872-8. PubMed ID: 16199833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cortical thickness during the course of illness in schizophrenia.
    van Haren NE; Schnack HG; Cahn W; van den Heuvel MP; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS
    Arch Gen Psychiatry; 2011 Sep; 68(9):871-80. PubMed ID: 21893656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
    Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
    Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia.
    Welch KA; Moorhead TW; McIntosh AM; Owens DG; Johnstone EC; Lawrie SM
    Psychol Med; 2013 Oct; 43(10):2087-96. PubMed ID: 23190458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients.
    Rais M; Cahn W; Van Haren N; Schnack H; Caspers E; Hulshoff Pol H; Kahn R
    Am J Psychiatry; 2008 Apr; 165(4):490-6. PubMed ID: 18281413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking and progressive brain volume loss in schizophrenia.
    Van Haren NE; Koolschijn PC; Cahn W; Schnack HG; Hulshoff Pol HE; Kahn RS
    Eur Neuropsychopharmacol; 2010 Jul; 20(7):454-8. PubMed ID: 20227855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient.
    Rais M; Cahn W; Schnack HG; Hulshoff Pol HE; Kahn RS; van Haren NE
    Psychol Med; 2012 Sep; 42(9):1847-56. PubMed ID: 22357376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tissue changes and antipsychotic medication.
    Puri BK
    Expert Rev Neurother; 2011 Jul; 11(7):943-6. PubMed ID: 21721911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia as a progressive brain disease.
    van Haren NE; Cahn W; Hulshoff Pol HE; Kahn RS
    Eur Psychiatry; 2008 Jun; 23(4):245-54. PubMed ID: 18513927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia.
    Rais M; van Haren NE; Cahn W; Schnack HG; Lepage C; Collins L; Evans AC; Hulshoff Pol HE; Kahn RS
    Eur Neuropsychopharmacol; 2010 Dec; 20(12):855-65. PubMed ID: 20863671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study.
    Stip E; Mancini-Marïe A; Letourneau G; Fahim C; Mensour B; Crivello F; Dollfus S
    Int Clin Psychopharmacol; 2009 Jan; 24(1):34-41. PubMed ID: 19077676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.
    Koenders L; Machielsen MW; van der Meer FJ; van Gasselt AC; Meijer CJ; van den Brink W; Koeter MW; Caan MW; Cousijn J; den Braber A; van 't Ent D; Rive MM; Schene AH; van de Giessen E; Huyser C; de Kwaasteniet BP; Veltman DJ; de Haan L
    J Psychiatry Neurosci; 2015 May; 40(3):197-206. PubMed ID: 25510948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia.
    Kaspárek T; Prikryl R; Mikl M; Schwarz D; Cesková E; Krupa P
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):151-7. PubMed ID: 17011096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.